Nuria Maroto
Manises, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Risk of symptomatic leishmaniasis in patients with inflammatory bowel disease receiving biologic therapy in an endemic Mediterranean region: a population-based case-control study.
Journal: Journal of Crohn's & colitis
Published: June 08, 2026
Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry.
Journal: Alimentary pharmacology & therapeutics
Published: March 28, 2026
Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry.
Journal: United European gastroenterology journal
Published: October 23, 2025
Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCU.
Journal: United European gastroenterology journal
Published: September 05, 2024
Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project.
Journal: Postgraduate medical journal
Published: February 10, 2024
Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn's Disease: A National, Multicentre Study Based on ENEIDA Registry.
Journal: Journal of Crohn's & colitis
Published: November 06, 2023
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885.
Journal: Journal of clinical medicine
Published: May 26, 2022
Ferric Carboxymaltose Improves the Quality of Life of Patients with Inflammatory Bowel Disease and Iron Deficiency without Anaemia.
Journal: Journal of clinical medicine
Published: April 21, 2022
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study.
Journal: Journal of clinical medicine
Published: May 19, 2021
Real-world data on the infliximab biosimilar CT-P13 (Remsima®) in inflammatory bowel disease.
Journal: World journal of clinical cases
Published: April 22, 2021
Recommendations of the Crohn's Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn's disease.
Journal: Gastroenterologia y hepatologia
Published: August 26, 2019
Validation of a population pharmacokinetic model of adalimumab in a cohort of patients with inflammatory bowel disease.
Journal: Revista espanola de enfermedades digestivas
Published: April 26, 2019
Last Updated: 09/26/2026